Navigation Links
Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights
Date:11/19/2009

122,061 ----- ----- ------ ------ ------- Loss from operations (4,527) (7,664) (15,443) (18,093) (117,658) Investment income 47 114 189 574 5,352 Interest expense (540) (52) (1,705) (90) (2,334) Other income (expense) 1,104 222 1,452 165 1,886 ----- --- ----- --- ----- Net loss $(3,916) $(7,380) $(15,507) $(17,444) $(112,754) ======= ======= ======== ======== ========= Basic and diluted net loss per common share $(1.34) $(2.54) $(5.29) $(6.07) ====== ====== ====== ====== Weighted- average shares used to compute basic and diluted net loss per common share 2,930,391 2,909,688 2,929,728 2,871,704 ========= ========= ========= ========= Pro forma basic and diluted net loss per common share $(0.33) $(0.52) $(1.14) $(1.21) ====== ====== ====== ====== Weighted- average pro forma shares used to compute pro forma basic and diluted net loss per share 14,444,897 14,301,745 14,422,465 14,263,761 ========== ========== ========== ========== OMEROS CORPORATION (A Development Stage Company) CONSOLIDATED BALANCE SHEETS (In thousands) September 30, December 31, 2009 2008 ---------- ---------- (unaudite
'/>"/>
SOURCE Omeros Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
2. Omeros Appoints David A. Mann to its Board of Directors
3. Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
4. Omeros and BlueCrest Announce $20 Million Debt Facility
5. Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery
6. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
7. Omeros Appoints New Vice President of Clinical Development
8. Omeros Announces Positive Clinical Results of Phase 1/Phase 2 Trial of OMS302 for Use During Ophthalmologic Surgery
9. Omeros Commences Initial Public Offering of Common Stock
10. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
11. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ... today announced next steps for its Oral Amphotericin ... from its in vitro work involving ... iCo now plans to complete pre clinical studies ... initial Phase 1A clinical trial, utilizing approximately $700,000 ...
(Date:10/20/2014)... 20, 2014 Mapp Biopharmaceutical,s valiant effort ... therapeutic to fight the Ebola outbreak will make ... the production of pharmaceuticals can be, according to ... that while some may be taken aback by ... with industry knowledge are well aware of the ...
(Date:10/20/2014)... Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Zola P. Horovitz , Ph.D., from its board of directors ... board in August 2003, and served as its chairman from ... served on the Nominating and Corporate Governance and Audit Committees ... for more than a decade of dedicated service to GenVec, ...
(Date:10/19/2014)... The Latin American hardware encryption display market report ... analysis and forecast of revenue. This market was valued ... reach $2,366.8 million by 2018, at a CAGR of ... TOC of the Latin American hardware encryption market report ... It also provides a glimpse of the segmentation of ...
Breaking Biology Technology:iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Zola P. Horovitz To Retire From GenVec Board 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 3
... Oct. 7 /PRNewswire-FirstCall/ - Resverlogix Corp.,("Resverlogix" or the ... recent significant market drop of Resverlogix shares management ... fundamentals remain the same if,not stronger in regards ... no reason for the price drop other than ...
... AMERIGROUP,Corporation (NYSE: AGP ) today announced that ... ended September 30, 2008, after the market closes ... Time on Thursday, October,23, 2008, AMERIGROUP,s management will ... and other information., To listen to the ...
... Mass., Oct. 7 BioEnergy International, LLC,(BioEnergy), ... renewable biochemicals and biofuels, announces the,addition of ... Advisors effective December,2008. Mr. Augustine has a ... highest level of industry and government culminating ...
Cached Biology Technology:AMERIGROUP Corporation to Discuss Third Quarter Earnings on October 23 2BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 2BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 3
(Date:10/15/2014)... of Life, is a non-traditional biophysics textbook and it ... is a journey of discovery into biological systems and ... biological regulation. It is about how our genes make ... the billions of cells in an organism. It quantifies ... principles, which can be found on both large and ...
(Date:10/15/2014)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ("NXT-ID" or ... commerce market releases photos and video of the recent opening bell ... th . Gino Pereira , CEO of ... Mr. Chad A. Verdi rang the bell.  ... and employees "for their work and dedication in bringing the world,s ...
(Date:10/14/2014)... published in Cancer Research shows SIRT6—a protein ... cancers—can promote the development of skin cancers by turning ... of sun-damaged skin cells. , Previously considered protective, SIRT6 ... sirtuins that help regulate genomic stability and prevent some ... repair DNA damage, which can lead to cancer. This ...
Breaking Biology News(10 mins):New book about life as seen from physics 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
... vessels in the body, called "angiogenesis," is usually discussed in ... ongoing process in the female reproductive tract, where the growth ... the menstrual cycle. But abnormal growth of blood vessels can ... Ruth Shalgi and research associate Dr. Dana Chuderland of Tel ...
... , April 3, 2013  NAPCO Security Technologies, Inc., (NASDAQ: ... suppliers of high performance electronic security equipment for over ... - West Conference and Exhibition , at the Sands Convention ... 2013. ISC West is one of the largest events in ...
... energy or one that,s environmentally destructive? That,s the question ... Society Forum session on fracking April 10, 2013 from 3 ... NJIT Technology and Society Forum is free and open to ... underground at high pressure to fracture rock formations in order ...
Cached Biology News:New relief for gynecological disorders 2New relief for gynecological disorders 3NAPCO Security Technologies, Inc. to Demonstrate New Product Capabilities at 2013 ISC West Conference and Exhibition 2NAPCO Security Technologies, Inc. to Demonstrate New Product Capabilities at 2013 ISC West Conference and Exhibition 3Fracking: Challenges and opportunities 2
... the computing power of your ValveBank system! ... sequences with a Macintosh computer using graphic ... to disk, print out program listings, then ... in one simple step., EasyCode is used ...
... series of Class II Biological Safety ... certification to the world's highest safety ... the cabinets cannot be adjusted out ... low noise and arm rest ensure ...
... is a dedicated fluorometer with ... kinds of assays in industrial ... clinical applications. Cell biology, immunology ... important application areas. Robot-friendly hardware ...
... class-leading features, the 1400 Series will maximize your comfort ... consistent every time you use it. , ... consumption by as much as 50% from competitive models, ... the cabinet. Multiply this savings by the number ...
Biology Products: